QIAGEN Exceeds Outlook for Fourth Quarter and Full-Year 2022 With 14% CER Sales Growth in FY 2022 From Non-COVID Product Groups

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. DOL:CN

Go back to QIAGEN Exceeds Outlook for Fourth Quarter and Full-Year 2022 With 14% CER Sales Growth in FY 2022 From Non-COVID Product Groups

Qiagen (QGEN) Tops Q1 EPS by 6c

February 7, 2023 4:15 PM EST

Qiagen (NYSE: QGEN) reported Q1 EPS of $0.53, $0.06 better than the analyst estimate of $0.47. Revenue for the quarter came in at $498 million versus the consensus estimate of $489.92 million.

For earnings history and earnings-related data on Qiagen (QGEN) click here.

... More